Logo
  • About
  • Technology
  • News
  • Contact
Logo
  • About
  • Technology
  • News
  • Contact
04
Jan
2019

Insusense Therapeutics website launches

News

Paul Little, Operating Partner in Lundbeckfonden Emerge, replaces Christian Elling as CEO of Insusense Therapeutics
1. October 2018
Lundbeck Foundation doubles its investment in Aarhus-based Insusense Therapeutics
20. October 2015

About Us

InsuSence Therapeutics is a product-focused biotechnology company based on novel breakthrough science in diabetes biology, which has the potential to quantum leap to important new Type 2 diabetes therapeutics.

News

Paul Little, Operating Partner in Lundbeckfonden Emerge, replaces Christian Elling as CEO of Insusense Therapeutics
1. October 2018
Lundbeck Foundation doubles its investment in Aarhus-based Insusense Therapeutics
20. October 2015

Contact

Insusense ApS
c/o Lundbeckfonden
Scherfigsvej 7
DK-2100 Copenhagen

  • Privacy Policy
Copyright © InsuSense Therapeutics, All Rights Reserved.